Alisa Lask Power - 10 Aug 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Role
Director
Signature
/s/ Brian Markison, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Aug 2023
Net transactions value
-$5,880
Form type
4
Filing time
14 Aug 2023, 17:35:04 UTC
Previous filing
11 Jul 2023
Next filing
15 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Tax liability $5,880 -12,000 -9.6% $0.4900 112,557 10 Aug 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.